Literature DB >> 33444383

Psychological, physical, and sleep comorbidities and functional impairment in irritable bowel syndrome: Results from a national survey of U.S. adults.

Madhusudan Grover1, Bhanu Prakash Kolla2, Rahul Pamarthy1, Meghna P Mansukhani3, Margaret Breen-Lyles1, Jian-Ping He4, Kathleen R Merikangas4.   

Abstract

BACKGROUND/AIMS: Patients with irritable bowel syndrome (IBS) in referral practice commonly report mental disorders and functional impairment. Our aim was to determine the prevalence of mental, physical and sleep-related comorbidities in a nationally representative sample of IBS patients and their impact on functional impairment.
METHODS: IBS was defined by modified Rome Criteria based on responses to the chronic conditions section of the National Comorbidity Survey-Replication. Associations between IBS and mental, physical and sleep disorders and 30-day functional impairment were examined using logistic regression models.
RESULTS: Of 5,650 eligible responders, 186 met criteria for IBS {weighted prevalence 2.5% (SE = 0.3)}. Age >60 years was associated with decreased odds (OR = 0.3; 95% CI:.1-.6); low family income (OR = 2.4; 95% CI:1.2-4.9) and unemployed status (OR = 2.3; 95% CI:1.2-4.2) were associated with increased odds of IBS. IBS was significantly associated with anxiety, behavior, mood disorders (ORs 1.8-2.4), but not eating or substance use disorders. Among physical conditions, IBS was associated with increased odds of headache, chronic pain, diabetes mellitus and both insomnia and hypersomnolence related symptoms (ORs 1.9-4.0). While the association between IBS and patients' role impairment persisted after adjusting for mental disorders (OR = 2.4, 95% CI 1.5-3.7), associations with impairment in self-care, cognition, and social interaction in unadjusted models (ORs 2.5-4.2) were no longer significant after adjustment for mental disorders.
CONCLUSION: IBS is associated with socioeconomic disadvantage, comorbidity with mood, anxiety and sleep disorders, and role impairment. Other aspects of functional impairment appear to be moderated by presence of comorbid mental disorders.

Entities:  

Year:  2021        PMID: 33444383      PMCID: PMC7808669          DOI: 10.1371/journal.pone.0245323

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  37 in total

1.  The US National Comorbidity Survey Replication (NCS-R): design and field procedures.

Authors:  Ronald C Kessler; Patricia Berglund; Wai Tat Chiu; Olga Demler; Steven Heeringa; Eva Hiripi; Robert Jin; Beth-Ellen Pennell; Ellen E Walters; Alan Zaslavsky; Hui Zheng
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

2.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

3.  The impact of functional gastrointestinal disorders on quality of life.

Authors:  N A Koloski; N J Talley; P M Boyce
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

4.  Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome.

Authors:  M M Heitkemper; K C Cain; W Deechakawan; A Poppe; S-E Jun; R L Burr; M E Jarrett
Journal:  Neurogastroenterol Motil       Date:  2012-04-03       Impact factor: 3.598

5.  Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.

Authors:  Ami D Sperber; Shrikant I Bangdiwala; Douglas A Drossman; Uday C Ghoshal; Magnus Simren; Jan Tack; William E Whitehead; Dan L Dumitrascu; Xuicai Fang; Shin Fukudo; John Kellow; Edith Okeke; Eamonn M M Quigley; Max Schmulson; Peter Whorwell; Timothy Archampong; Payman Adibi; Viola Andresen; Marc A Benninga; Bruno Bonaz; Serhat Bor; Luis Bustos Fernandez; Suck Chei Choi; Enrico S Corazziari; Carlos Francisconi; Albis Hani; Leonid Lazebnik; Yeong Yeh Lee; Agata Mulak; M Masudur Rahman; Javier Santos; Mashiko Setshedi; Ari Fahrial Syam; Stephen Vanner; Reuben K Wong; Aurelio Lopez-Colombo; Valeria Costa; Ram Dickman; Motoyori Kanazawa; Ammar Hassanzadeh Keshteli; Rutaba Khatun; Iradj Maleki; Pierre Poitras; Nitesh Pratap; Oksana Stefanyuk; Sandie Thomson; Judith Zeevenhooven; Olafur S Palsson
Journal:  Gastroenterology       Date:  2020-04-12       Impact factor: 22.682

6.  Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

Authors:  Gilles Bommelaer; Thierry Poynard; Claude Le Pen; Anne-Françoise Gaudin; Frédérique Maurel; Gaël Priol; Michel Amouretti; Jacques Frexinos; Philippe Ruszniewski; Abdelkader El Hasnaoui
Journal:  Gastroenterol Clin Biol       Date:  2004 Jun-Jul

7.  Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders.

Authors:  Madhusudan Grover; Spencer D Dorn; Stephan R Weinland; Christine B Dalton; Bradley N Gaynes; Douglas A Drossman
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

8.  Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database Study.

Authors:  Tse-Yen Yang; Chih-Sheng Chen; Cheng-Li Lin; Wei-Ming Lin; Chua-Nan Kuo; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

9.  Biopsychosocial Aspects of Functional Gastrointestinal Disorders.

Authors:  Lukas Van Oudenhove; Michael D Crowell; Douglas A Drossman; Albena D Halpert; Laurie Keefer; Jeffrey M Lackner; Tasha B Murphy; Bruce D Naliboff; Rona L Levy
Journal:  Gastroenterology       Date:  2016-02-18       Impact factor: 22.682

Review 10.  The epidemiology of irritable bowel syndrome.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  Clin Epidemiol       Date:  2014-02-04       Impact factor: 4.790

View more
  6 in total

1.  Risk Factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in Adults and Children: A Systematic Review.

Authors:  Jasmine K Zia; Adrienne Lenhart; Pei-Lin Yang; Margaret M Heitkemper; Jason Baker; Laurie Keefer; Miguel Saps; Callie Cuff; Gregory Hungria; Elizabeth J Videlock; Lin Chang
Journal:  Gastroenterology       Date:  2022-06-16       Impact factor: 33.883

2.  The Prevalence of Irritable Bowel Syndrome Among Chinese University Students: A Systematic Review and Meta-Analysis.

Authors:  Weixin Yang; Xiao Yang; Xianghao Cai; Zhuoren Zhou; Huan Yao; Xingrong Song; Tianyun Zhao; Peng Xiong
Journal:  Front Public Health       Date:  2022-04-15

3.  Single-Session Acceptance and Commitment Therapy (ACT) Interventions for Patients with Chronic Health Conditions: A Systematic Review and Meta-Analysis.

Authors:  Cara Dochat; Jennalee S Wooldridge; Matthew S Herbert; Michael W Lee; Niloofar Afari
Journal:  J Contextual Behav Sci       Date:  2021-03-06

4.  Associations between physical multimorbidity patterns and common mental health disorders in middle-aged adults: A prospective analysis using data from the UK Biobank.

Authors:  Amy Ronaldson; Jorge Arias de la Torre; Matthew Prina; David Armstrong; Jayati Das-Munshi; Stephani Hatch; Rob Stewart; Matthew Hotopf; Alexandru Dregan
Journal:  Lancet Reg Health Eur       Date:  2021-06-22

5.  A questionnaire-based survey on the etiopathogenesis of chronic constipation during a medical check-up in Japan.

Authors:  Koji Otani; Toshio Watanabe; Kanae Takahashi; Masaki Ominami; Yuji Nadatani; Shusei Fukunaga; Shuhei Hosomi; Noriko Kamata; Fumio Tanaka; Yasuaki Nagami; Koichi Taira; Tatsuo Kimura; Shinya Fukumoto; Yasuhiro Fujiwara
Journal:  J Clin Biochem Nutr       Date:  2022-01-19       Impact factor: 3.114

6.  Cognitive Behavioral Therapy-Based Comprehensive Self-Management Program Improves Presenteeism in Persons with Irritable Bowel Syndrome: A Secondary Data Analysis.

Authors:  Pei-Lin Yang; Sarah W Matthews; Robert L Burr; Kevin C Cain; Pamela G Barney; Jasmine K Zia; Margaret H Heitkemper; Kendra J Kamp
Journal:  Int J Environ Res Public Health       Date:  2022-03-04       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.